Our Plans for the Future

Total Page:16

File Type:pdf, Size:1020Kb

Our Plans for the Future Patient Focus Spring 2014.qxd:Layout 1 07/05/2014 14:27 Page 2 A lifetime of specialist care D 0 P 0 m E 0 e A 0 PatientThe newsletter for patients and ourFocus foundation trust members | Issue 3 – Spring 2014 g 1 0 0 e Royal Brompton Hospital 0 2 s 0 Welcome to 0 – our plans for the future a h 0 Royal Brompton & Harefield NHS Investment in Harefield Hospital is the latest issue j Foundation Trust is the UK’s leading ongoing and there are no plans to centre for heart and lung disease; sell or move from this well- It is an exciting time for the Trust as plans progress to rebuild Royal Brompton Hospital, 0 two of the world’s biggest killers. established site. consolidating services on one state-of-the-art i Investing in new and existing 0 Exhibition of plans facility in Sydney Street. It is vital that we raise n facilities at Royal Brompton Hospital the appropriate funding to enable this is essential. It is increasingly difficult A four-day public exhibition was ambitious project to go ahead. More details to deliver the care patients deserve held in February to share the opposite. 0 1 from some of our ageing buildings. evolving plans for Royal Brompton. a 0 We need 21st century state-of-the Over 330 people attended the We began a series of member events in 2013; a art facilities to continue to save lives exhibition and the majority the first in October and the second in November – read about them on page 2. More events are w and provide world-class care for expressed support for the planned for this year and will be advertised in 0 patients. Having assessed the redevelopment plans. A further d @ possible options, including exhibition will be held in June and Patient Focus and the members’ section of the Trust’s website. relocating, the Trust Board has taken we encourage you to come along the decision to continue developing and find out more about our exciting We are pleased to welcome five new governors on the current Sydney Street site in and ambitious plans for the future. to the Trust and we look forward to the valuable U L Chelsea. contributions they will make to our work. You 3 Want to know more? can read more about them on pages 4 and 5. The costs will be substantial – in the 0 l region of £580 million – but the You can visit our redevelopment If you are interested in contributing to our h w website – http://royalbrompton long-term benefits will be exciting research work in heart and/or lung h consultation.rbht.nhs.uk/ – to see @ enormous. To achieve this, we need heath, see pages 8-9 for more to sell property in the local area the plans, read the feedback from information. 2 owned by the Trust and its Charity the first exhibition and stay up to 0 F Finally, I hope you enjoy for the highest possible return, date with all the issues and progress. o 0 reading Patient Focus. h c which will allow us to invest the If you have any questions, please get money into providing a truly modern in touch with our community hospital. This means we need to gain consultation team. permission from the Royal Borough of Kensington & Chelsea to sell Freephone: 0800 881 5442 0 B some property for residential use. Email: [email protected] 0 i Put simply, if we cannot raise Philippa Allibone, c enough money, we cannot improve Freepost RTBH-CATL-ZXGT membership w our facilities to the level needed and Director of Capital Projects and manager we will be forced to continue Development 1 0 applying costly temporary fixes and Royal Brompton Hospital K remedial works so that our patients Sydney Street 0 k can get the care they need. London SW3 6NP Outpatients’ service evaluation for Have your say on our strategic plans Diary dates patients with a disability Pages 6-7 Page 11 Page 3 Patient Focus Spring 2014.qxd:Layout 1 07/05/2014 14:27 Page 3 page 2 – Patient Focus Spring 2014 Cardiac catheter laboratories tour – Harefield Hospital The Trust’s inaugural members’ event was held on Wednesday 16 October – a “behind the scenes” look at the cardiac catheterisation laboratories at Harefield Hospital. Mark Bowers, catheter lab manager, led the tour, giving a brief history of Harefield and explaining the primary angioplasty 5Chris Prytherch, radiographer, with visitors to Harefield Hospital programme, which has one of the fastest arrival-to-treatment times in the UK – a critical element in patients’ survival. Members were impressed by the enthusiasm and knowledge of Primary angioplasty is an emergency treatment for heart the staff involved and gave us some excellent feedback: attack. “Excellent explanations, well illustrated by seeing the actual Members took the opportunity to find out more about cardiac equipment (X-rays) and products used (stents).” electrophysiology, the X-ray equipment and the different types “Very informative and very reassuring. Particularly if an of procedures performed in the cath labs. They were shown individual has to have one of the procedures discussed.” pictures of angiograms and a cardiac stent being inserted into a coronary artery and were able to closely examine the cardiac “Delightful staff who took interest in explaining. A ‘big thank you’ catheters and stents. to everybody in the labs”. “Advances in cardiomyopathy” – Royal Brompton On Wednesday 27 November, over 30 Royal Brompton & Harefield NHS cardiomyopathy, to the podium to talk Trust members attended a talk entitled Foundation Trust is active in research in about living with the condition, the “Advances in cardiomyopathy – what we cardiomyopathy, which Dr Prasad agrees symptoms of which he had first are doing and where we are going” by Dr is the way forward in discovering the experienced as a child when he became Sanjay Prasad, consultant cardiologist at best treatments. For example, breathless after the smallest exertion. Royal Brompton Hospital. cardiovascular magnetic resonance (CMR) He has been a patient at Royal Brompton has already proved a better tool for Cardiomyopathy is a disease of the heart for 10 years, and said the care and diagnosing heart failure caused by muscle and a leading cause of heart treatment he has received have greatly dilated cardiomyopathy (DCM) than a failure. Dr Prasad explained the different contributed to the good quality of his standard angiogram. Dr Prasad showed types of cardiomyopathy: hypertrophic, life now. images of several cases of dilated and arrhythmogenic right cardiomyopathy, explaining their Several members asked pertinent ventricular. He also spoke about chronic background and the differences between questions about the MRI images and heart failure treatments, prognosis, each. were also keen to know how to improve morbidity and prevention. the quality of life of patients with Genetic research is also important and a One of the most important approaches cardiomyopathy. recent breakthrough has identified a for the successful treatment of mutation in the Titin gene, which is One member commented: cardiomyopathy is early diagnosis and, as found in one in four patients diagnosed the disease is often inherited, Dr Prasad “The talk was interesting, simple to with DCM. and colleagues have started a understand and informative. The time cardiomyopathy clinic, where an entire Towards the end of his talk, Dr Prasad flew by. I could have stayed listening family can be screened for the condition. invited Mr Peter Klinger, a patient with all night.” Patient Focus Spring 2014.qxd:Layout 1 07/05/2014 14:27 Page 4 Patient Focus Spring 2014 – page 3 Outpatients’ service evaluation for patients with a disability We evaluated outpatients’ services at made the following changes to improve ¼ Provided more water coolers for patient Royal Brompton Hospital between the experience for patients: use. February and April 2013 to gain ¼ Trained outpatient staff and those ¼ Refurbished some treatment rooms. information on how we can improve the working in adult congenital heart experience of patients with a physical ¼ Employed a new ECHO technician for disease and the pulmonary patients with adult congenital heart and learning disability. hypertension teams in communication disease. The evaluation involved six patients with and Makaton (a type of sign language) physical and learning disabilities, and skills. ¼ Updated information about disabled parking on the Trust website. their carers, who were shadowed during ¼ Added a sign outside Chelsea Wing their outpatient visits and interviewed advising wheelchair patients to use the We have undertaken a similar service afterwards. Shadowing patients was Sydney St entrance. Information has evaluation in outpatients at Harefield found to be extremely insightful, also been included in outpatient letters Hospital. Results will be available soon. particularly with patients who often for patients having an echocardiogram If you would like to know more about the experience difficulty in communicating. (ECHO). evaluation, please contact: Melanie Foody, Staff, including consultants, nurse ¼ Re-arranged seating in outpatients for patient experience and patient & specialists and clinical support assistants easier access for wheelchairs and involvement engagement manager, on were also interviewed. created a designated area for email: [email protected] or As a result of the evaluation, we have wheelchair users. telephone: 020 7351 8208. Adult congenital heart disease meeting for patients and their families The adult congenital heart disease (ACHD) team held its fourth annual patient and family conference day at Royal Brompton in March. ACHD consultants, clinical nurse specialists and members of the arrhythmia and psychology teams shared their expertise with over 40 patients and relatives. Attendees took part in focus groups and discussions to share their experiences 5Suzanne Rowsell talks to a patient at the conference with each other.
Recommended publications
  • Confirmed Minutes of the London Regional Transfusion
    The London Regional Transfusion Committee Confirmed Minutes of the London Regional Transfusion Committee London Blood Transfusion Forum (RTC Business Meeting) held on 14 October 2016 at The Atrium, Royal Free Hospital Present: Abdul Adamu (AA) Whttington Hospital Anita Aggrey (AAG) Barnet General Hospital Shubha Allard (SA) Barts Health/NHSBT Magda Al-Obaidi (MAO) West Middlesex University Hospital Mariam Ammoun (MA) Hammersmith Hospital Namal Bandara (NB) Kings College Hospital Lorraine Barwick (LB) Great Ormond Street Hospital Chetan Bhatt (CB) Whittington Hospital Dilraj Birdee (DB) Hammersmith Hospital Heather Brotherton (HB) Chase Farm Hospital Alison Brownell (AB) Queens Hospital Romford Elaine Carter-Leay (ECL) Queens Hospital Romford Sandeepa Chandarana (SC) Barnet General Hospital Vashira Chiroma (VC) Hammersmith Hospital Gavin Cho (GC) NHSBT Sarah Clark (SC) Royal Free Hospital Michelle Conway (MC) Harefield Hospital Bernadette Cruz (BC) Northwick Park Hospital Helena Day (HD) Harefield Hospital Ciara Donohue (CD) Royal Free Hospital Oluwatola Elegbe (OE) Barts Health Fernando Fegarido (FF) Kings College Hospital Matthew Free (MF) SWL Pathology - St. George’s Hospital Diana Gabriel (DG) Barts Health Champika Gamlath (CG) Kings College Hospital Lisa Gibb (LG) Great Ormond Street Hospital Jan Gordon (JG) Chelsea & Westminster Hospital Christy Green (CG) Royal London Hospital Jane Harris (JH) New Victoria Hospital Amanda Hobson (AH) Royal Free Hospital Dena Howlett (DH) Epsom General Hospital Charmaine Jardiel (CJ) West Middlesex
    [Show full text]
  • RBH-CHD Network Annual Report.Pdf
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2018/19 Annual Report Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: For reference only Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Link - Contents 1 Contents Page 1 Contents Page .......................................................................................................................................... 2 2 A message from our Clinical Director ................................................................................................... 4 3 RBH-CHD Network Strategic Vision Statement .................................................................................. 5 4 Summary of Achievements Against our Work Plan – 2018/19 ......................................................... 5 5 Research ................................................................................................................................................... 6 5.1 Grants Awarded ................................................................................................................................ 7 5.2 Research Programmes Peer Reviewed Publications ................................................................. 7 5.3 Research Strategy
    [Show full text]
  • Royal Brompton Hospital Nhs Trust
    ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST LOCUM CONSULTANT IN CYSTIC FIBROSIS Applications are invited for the post of Locum Consultant in Cystic Fibrosis six month fixed term contract. The Royal Brompton & Harefield NHS Foundation Trust is seeking to appoint a LOCUM CONSULTANT IN CYSTIC FIBROSIS to be based at the Royal Brompton Hospital. The Trust is a world famous organisation with a proud history in the investigation, treatment and research of lung and heart disease. We are particularly proud of our ability to provide comprehensive specialist care for patients of all ages and their families. The post will be based at The Royal Brompton Hospital and the successful candidate will work closely with the current physicians in the Cystic Fibrosis Unit to lead the cystic fibrosis service, which attracts tertiary referrals from all over the UK. Applicants are required to be fully registered Medical Practitioners and must be on the GMC’s Specialist Register or be eligible for admission to the Register within three months from date of interview for the post. Informal enquiries may be made to Dr Nicholas Simmonds, Consultant in Respiratory Medicine on 0207 351 8997. For an application form and job description, please contact our Medical Recruitment Manager by email on [email protected] or 0207 351 8688 quoting reference number 312-LC-CF-0915 and we will organise for an application pack to be sent out to you. Alternatively, applications can be made via the NHS jobs website www.jobs.nhs.uk We regret that we are unable to contact applicants who are not selected for an interview, therefore if you do not hear from us within three weeks after the closing date, please assume you have not been successful on this occasion.
    [Show full text]
  • Studies of ACE-Inhibition and Nitrate Supplementation
    Augmenting Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: Studies of ACE-inhibition and Nitrate Supplementation Katrina Jane Curtis The Muscle Laboratory, Royal Brompton Hospital National Heart & Lung Institute, Imperial College London Submitted for the degree of Doctor of Philosophy (PhD) Imperial College London 1 Declaration of originality The data present in this thesis are the result of my original work. Where appropriate the contribution made by other persons has been appropriately acknowledged. Statement of contribution Contributions were made by Kawah Li and Professor Hugh Montgomery at University College London, who performed the ACE genotyping. In addition, Magda Minnion and Professor Martin Feelisch at the University of Southampton performed the measurement of the plasma nitrate and nitrite levels. Juliet Polkey provided assistance with the isotime data analysis in the nitrate supplementation work. Victoria Meyrick and Bhavin Mehta led the pulmonary rehabilitation programme at the Royal Brompton Hospital, and the team at Harefield Hospital are also acknowledged for their assistance in this respect. Copyright declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives license. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the license terms of this work. Sources of funding The research in the thesis was funded by the Medical Research Council (grant reference MR/J000620/1) and the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, where it was undertaken.
    [Show full text]
  • FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub áRea
    Ranking Instituciones No Académicas por sub área OCDE 2020 6. Humanidades > 6.03 Filosofía, Ética y Religión PAÍS INSTITUCIÓN RANKING PUNTAJE FRANCE Centre National de la Recherche Scientifique (CNRS) 1 5,000 RUSSIA Russian Academy of Sciences 2 5,000 USA National Institutes of Health (NIH) - USA 3 5,000 RUSSIA Institute of Philosophy, Russian Academy of Sciences 4 5,000 SPAIN Consejo Superior de Investigaciones Cientificas (CSIC) 5 5,000 USA Seattle Children's Hospital 6 5,000 USA NIH Clinical Center (CC) 7 5,000 USA VA Boston Healthcare System 8 5,000 SLOVAKIA Slovak Academy of Sciences 9 5,000 ARGENTINA Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) 10 5,000 SPAIN CSIC - Instituto de Lenguas y Culturas del Mediterraneo y Oriente Proximo (ILC) 11 5,000 NETHERLANDS Erasmus University Medical Center 12 5,000 NETHERLANDS Academic Medical Center Amsterdam 13 5,000 USA Harvard School of Dental Medicine 14 5,000 GERMANY Helmholtz Association 15 5,000 USA University of Illinois Chicago Hospital 16 5,000 USA Mayo Clinic 17 5,000 FRANCE CNRS - Institute for Humanities & Social Sciences (INSHS) 18 5,000 GERMANY Max Planck Society 19 5,000 AUSTRALIA Florey Institute of Neuroscience & Mental Health 20 5,000 USA The World Bank 21 5,000 CZECH REPUBLIC Czech Academy of Sciences 22 5,000 USA NIH National Institute of Environmental Health Sciences (NIEHS) 23 5,000 NETHERLANDS VU UNIVERSITY MEDICAL CENTER 24 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 25 5,000 NETHERLANDS Utrecht University Medical
    [Show full text]
  • What Do Imperial Medicine* Postgraduates Do?
    What do Imperial Medicine* postgraduates do? Graph 1 – Destinations of 2016 graduates Percentage Entered Employment 66% Entered Further Study/Training 30% Seeking Employment 2% Not Available for Employment/Study/Training 2% Graph 2 – Comparison with previous years 2014 2015 2016 Entered Employment 56% 71% 66% Entered Further Study/Training 32% 23% 30% Seeking Employment 5% 3% 2% Not Available for Employment/Study/Training 7% 3% 2% Graph 3 – Sector of employment entered 2014 2015 2016 Agriculture 0.0% 0.6% 0.0% Oil/Mining 0.0% 0.0% 0.0% Manufacture 2.5% 4.1% 3.8% Utilities & Transport 0.0% 0.0% 0.0% Technical Consultancy/R&D 5.8% 2.4% 3.2% IT & Telecommunications 1.7% 2.9% 0.6% Banking/Financial 1.7% 0.0% 1.3% Accountancy 1.7% 0.6% 0.6% Business & Management Consultancy 1.7% 1.8% 0.6% Other Business Activities 5.0% 4.1% 6.4% Public Administration/Defence 1.7% 5.3% 6.4% Education 38.3% 23.5% 23.7% Health/Social Work 36.7% 52.9% 50.0% Others 3.3% 1.8% 3.2% *This data incorporates the Departments of Medicine; the Institute of Clinical Science; Public Health; Surgery & Cancer; and the National Heart and Lung Institute Careers Service www.imperial.ac.uk/careers Postgraduate Taught Courses Examples of employers and occupations for Medicine et al taught postgraduates who entered employment Examples of Employers Examples of Occupations • Academy of Education Development • Academic Clinical Fellow in General Practise • Aintree Hospital • Account Executive • Assemblies of God church • Associate Project Manager • Associate • Associate Scientist •
    [Show full text]
  • VIVOTM Non-Invasive Time Assessment Protocol
    TM VIVO non-invasive Time Assessment Protocol Short Study Title/Acronym: VIVOTM mapping Protocol REC Reference: Insert REC Reference IRAS Reference: 257755 CHIEF INVESTIGATOR: Dr Sabine Ernst, Consultant Cardiologist and Reader in Cardiology, Lead for Electrophysiology Research for the Royal Brompton Hospital Royal Brompton Hospital (RBH) Sydney Street London SW3 6NP Phone: 00442073518612 Email: [email protected] Fax: 00442073518131 SPONSOR REPRESENTATIVE: Mr Patrik Pettersson Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) Royal Brompton Hospital (RBH) Research Office Chelsea Wing, Level 2 Sydney Street London SW3 6NP Phone: 0207 352 8121 ext. 8736 Email: [email protected] Fax: 0207 351 8829 VIVOTM mapping protocol VIVO-RBH01 Revision A – 15th January 2019 Page 1 of 38 Information in this protocol is confidential and should not be disclosed, other than to those directly involved in the execution or the ethical review of the study, without written authorisation from RB&HFT Research Office. Signature Page The Chief Investigator (CI) and the Research Office have discussed and agreed this study protocol. The investigators agree to perform the investigations outlined in this study protocol and to abide by this protocol except in the case of medical emergency that will be notified to the Research Office. The Investigator agrees to conduct the study in compliance with the study protocol and/or any subsequent amendments approved by the Sponsor and HRA, the Data Protection Act (1998), the Trust Information Governance Policy (or other local equivalent as applicable), the Research Governance Framework for Health & Social Care, 2nd Edition (2005), the Sponsor’s SOPs, and any other applicable regulatory requirements.
    [Show full text]
  • The Royal Brompton & Harefield Hospital NHS Foundation Trust
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2019 / 20 Annual Business Plan Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: All Document Authors Meeting Chair Meeting Members Network Management Team Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Contents Page Link 1 Contents 1 Contents ................................................................................................................................................................... 2 2 The Brompton Hospital and Congenital Heart Disease ................................................................................... 3 3 The Annual Business Plan .................................................................................................................................... 3 4 Governance & Committee Structure ................................................................................................................... 3 5 RBH-CHD Strategic Vision ................................................................................................................................... 4 6 Operational Delivery Network ..............................................................................................................................
    [Show full text]
  • Efficacy and Safety of TOBI Podhaler in Pseudomonas Aeruginosa-Infected Bronchiectasis Patients: Ibest Study
    ORIGINAL ARTICLE BRONCHIECTASIS Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study Michael R. Loebinger1,2, Eva Polverino3, James D. Chalmers4, Harm A.W.M. Tiddens5,6, Herman Goossens7, Michael Tunney8, Felix C. Ringshausen 9, Adam T. Hill10, Rashidkhan Pathan11, Gerhild Angyalosi12, Francesco Blasi 13,14, Stuart J. Elborn2,15,16 and Charles S. Haworth17,18 on behalf of the iBEST-1 Trial Team Affiliations: 1Host Defence Unit, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK. 2Imperial College London, London, UK. 3Respiratory Disease Department, Vall d’ Hebron University Hospital – VHIR, Barcelona, Spain. 4Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. 5Dept of Paediatric Pulmonology and Allergology, Erasmus Medical Centre Sophia Children’s Hospital, Rotterdam, The Netherlands. 6Dept of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands. 7Dept of Clinical Microbiology, University Hospital Antwerp, Antwerp, Belgium. 8Halo Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UK. 9Dept of Respiratory Medicine, Hannover Medical School, and Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany. 10Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, and University of Edinburgh, Edinburgh, UK. 11Novartis Healthcare Private Limited, Hyderabad, India. 12Novartis Pharma AG, Basel, Switzerland. 13Internal Medicine Dept, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. 14Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. 15Halo Research Group, Centre for Experimental Medicine, Queen’s University Belfast, Belfast, UK. 16Imperial College and Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK.
    [Show full text]
  • Joint Appointment of Consultant Neurologist
    Joint Appointment of Consultant Neurologist Emergency Care and Integrated Care Division, Chelsea and Westminster Hospital – 8PA Regional Neurosciences Unit, Imperial College Hospitals, Charing Cross Hospital – 2PA JOB DESCRIPTION About our organisation Chelsea and Westminster Hospital NHS Foundation Trust provide services from two main hospitals, Chelsea and Westminster Hospital and West Middlesex University Hospital, and a number of clinics across London and the South-East. We have nearly 6,000 members of staff that care for nearly one million people locally, regionally, nationally and internationally. Both hospitals provide full clinical services, including full maternity, emergency and children’s, in addition to a range of community-based services across London, such as award-winning sexual health and HIV clinics. We are one of the best performing FTs in London for A&E waiting times, and mortality rates are better than average. Since the Care Quality Commission last inspected our hospitals we have taken on responsibility for a range of new services. Our new services include: Cardiac catheter service and a paediatric assessment unit on the West Middlesex site Surgical assessment unit on the Chelsea site New sexual health clinic at 10 Hammersmith Broadway Virtual fracture clinics Learning disabilities passports Plans are in place for a £20 million expansion to critical care facilities and refurbishment of the children’s unit at West Middlesex, both in partnership with the Trust’s dedicated charity CW+. Our priorities 1. Deliver high-quality patient-centred care Patients, their friends, family and carers will be treated with unfailing kindness and respect by every member of staff in every department and their experience and quality of care will be second to none.
    [Show full text]
  • Patient Booklet 03/09/2014 16:41 Page 2
    Info for patients - RBH.qxp:Patient Booklet 03/09/2014 16:41 Page 2 A lifetime of specialist care Royal Brompton Hospital Information for inpatients Info for patients - RBH.qxp:Patient Booklet 03/09/2014 16:41 Page 3 Table of contents Before you come into hospital 3 Coming into hospital 5 Arriving at hospital 7 Hospital staff 8 On and around the ward 11 Visitors 13 Your rights while in hospital 16 Going home 19 Feedback 20 Royal Brompton & Harefield Hospitals Charity 22 Hospital volunteers 23 This leaflet gives you general information about your stay at Royal Brompton Hospital. Our hospital is a national and international centre for the treatment of, and research into, heart and lung disease. Please ask us if you have any questions. 2 Info for patients - RBH.qxp:Patient Booklet 03/09/2014 16:41 Page 4 Information for inpatients Before you come into hospital Please read this booklet before What to bring with you you come into hospital. You will also have received your Registration form registration form and Please bring your completed admission letter. Please read registration form with you, them carefully. along with your admission letter. Bed availability Royal Brompton & Harefield Medicines and prescription NHS Foundation Trust is a It is important that you bring specialist centre for heart and your current prescription and lung disease and we accept all the medicines you are patients from all over the taking with you to hospital in United Kingdom. Sometimes, their original containers. These emergency patients have to should include any medicines take priority and we have to you may have bought over the cancel or delay planned counter without a admissions.
    [Show full text]
  • Appendix G Royal Brompton Harefield NHS Foundation Trust Private
    private patients’ centre Royal Brompton and Harefield Hospitals London Royal Brompton & Harefield Brompton Royal 04 our mission 06 our reputation 11 patient services 18 personalised service and specialised care 24 location and contact information 25 pricing policy 2 private patients centre patients private Welcome to Royal Brompton and Harefield Hospitals Private Patients’ Centre A warm welcome to Royal Brompton and Harefield Hospitals Private Patients’ Centre. This brochure provides valuable information on the important, life-changing work we do for people with heart and lung conditions. It will help you form a picture of the services we provide, the people who deliver the clinical expertise and care that contributes to our world-class reputation, and the environment in which our complex clinical and research work takes place. The hospitals are the largest specialist heart and lung centre in the UK and among the largest in Europe. We welcome patients and attract staff from all over the world. So from the moment you first come into contact with us, until the time you leave, you will become part of a community of people who have benefited from over 160 years of expert diagnosis, treatment and care of cardiac and thoracic conditions. We look forward to welcoming you here in London in the very near future. 3 Royal Brompton & Harefield & Brompton Royal our mission International leadership for the benefit of all Our vision is to maintain and strengthen our They provide specialist care and create and reputation as the leading national and disseminate clinical knowledge that will international centre for the diagnosis, benefit people today and the generations treatment and care of people with heart and to come.
    [Show full text]